| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106680 Joining preferential nucleotide sequences; generate solid phase, incubate with nucleotide sequences, remove nucleotide sequence which have protrusions from terminals, recover bound nucleotide sequences |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106378 Materials and methods for intracellular transport and their uses |
| 08/08/2002 | US20020106370 Improvements in or relating to peptide delivery |
| 08/08/2002 | CA2766160A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2426818A1 Control of gene expression in plants |
| 08/07/2002 | EP1229113A2 Recombinational cloning using engineered recombination sites |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1228235A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228214A2 Erythropoietin forms with improved properties |
| 08/07/2002 | EP1228206A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1227848A2 Method for linking molecular substances |
| 08/07/2002 | EP1227829A2 Novel chimeric analgesic peptides |
| 08/07/2002 | EP1073763A4 Methods for transducing fusion molecules |
| 08/07/2002 | EP0762895B1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 08/07/2002 | CN1362969A Antimicrobial/endotoxin neutralizing polypeptide |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/01/2002 | WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059282A2 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059150A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 08/01/2002 | WO2002058723A2 Chemokines as adjuvants of immune response |
| 08/01/2002 | WO2002032923A3 Improved formulations using heat shock/stress protein-peptide complexes |
| 08/01/2002 | WO2002020614A3 Endoglin-specific polypeptide, production and use thereof |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same |
| 08/01/2002 | WO2001096565A3 Binding agents: chimeric ligand/receptor proteins |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | US20020104117 Nucleotide sequence coding for use as tools in the generation of disease and herbicide resistant plants |
| 08/01/2002 | US20020104113 Nav2 channel gene-deficient non-human animals |
| 08/01/2002 | US20020103358 Nucleotide sequences coding preferential polypeptide for use in tumor therapy |
| 08/01/2002 | US20020103343 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease |
| 08/01/2002 | US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | CA2440703A1 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434320A1 Chemokines as adjuvants of immune response |
| 08/01/2002 | CA2429779A1 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 07/31/2002 | EP1227321A1 Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| 07/31/2002 | EP1227147A2 Recombinational cloning using engineered recombination sites |
| 07/31/2002 | EP1226256A1 Recombinant therapeutic fusion proteins |
| 07/31/2002 | EP1226250A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226178A1 Recombinant fusion molecules |
| 07/31/2002 | EP1226168A1 Ligand activated transcriptional regulator proteins |
| 07/31/2002 | EP0920630B1 Prion binding proteins and uses thereof |
| 07/31/2002 | EP0708656B1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426075 Genetic engineered polypeptide; killing cancer cells |
| 07/30/2002 | CA2226293C Hcv ns3 protein fragments having helicase activity and improved solubility |
| 07/30/2002 | CA2084673C 16 kda surface protein of p.falciparum |
| 07/25/2002 | WO2002057792A2 Affinity selection-based screening of hydrophobic proteins |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057451A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/25/2002 | WO2002057435A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 07/25/2002 | WO2002057413A2 Peptides for activation and inhibition of delta pkc |
| 07/25/2002 | WO2002056910A1 Binding domain-immunoglobulin fusion proteins |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 07/25/2002 | WO2002010196A3 Identification of a novel glutamine transporter |
| 07/25/2002 | WO2002006463A3 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 07/25/2002 | WO2002006306A3 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 07/25/2002 | WO2001030812A9 Activation of hcv-specific t cells |
| 07/25/2002 | WO2001009187A9 Human monoclonal antibodies to her2/neu |
| 07/25/2002 | WO2001003723A9 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/25/2002 | WO2001001150A9 Diagnostic test for thrombotic or thromboembolic disease |
| 07/25/2002 | US20020100069 Treating heart defects; obtain tissue, incubate with modulator of transcription, evaluate tissue for defect |
| 07/25/2002 | US20020099181 Anti-fibroblast growth factor-8 monoclonal antibody |
| 07/25/2002 | US20020099024 Including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell. |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020099010 Neurogenic compositions and methods |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |